Physician profile
Jorge O Gomez Alarcon
NPI 1487183604
$71,697.02
in general payments reported to CMS, 2019-2025
19 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,770 · 2022: $7,010 · 2023: $25K · 2024: $24K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $26K · Travel and Lodging: $23K · Food and Beverage: $11K · Education: $937.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $25,625.00 |
| Travel and Lodging | $22,990.52 |
| Food and Beverage | $11,364.65 |
| Education | $936.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24,539.89 | 2021-2025 | Ensite Precision, Ensite, Gallant |
| Boston Scientific Corporation | $14,839.45 | 2023-2025 | General - Ep, Emblem Mri S-Icd, Versacross Access Solution |
| Medtronic, INC. | $11,224.45 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Affera Mapping System |
| Biotronik INC. | $9,662.57 | 2022-2025 | Pamira, Amvia Edge, Selectra |
| Medical Device Business Services, INC. | $5,922.89 | 2022-2024 | Carto 3 |
| Biosense Webster, INC. | $2,468.36 | 2021-2025 | Carto 3, Na, Soundstar |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,196.03 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $689.13 | 2021-2022 | |
| Philips North America LLC | $272.20 | 2022-2024 | (9520) Igt Devices Undivided, (9520) Igt Devices Und |
| Chiesi USA, INC. | $147.75 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $146.33 | 2021-2022 | |
| Cardiva Medical, INC. | $104.43 | 2023 | |
| Pfizer INC. | $100.92 | 2022-2024 | |
| Novo Nordisk INC | $81.70 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $79.98 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $69.15 | 2023-2025 | |
| Getinge USA Sales, LLC | $66.00 | 2021-2023 | Cs300 Intra-Aortic Balloon Pump, English, 110v |
| Cordis US Corp. | $58.66 | 2023-2025 | Mynxgrip, Mynx Control, Mynx Control Venous |
| Abiomed | $27.13 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Gomez Alarcon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.